Clinical trialPhase 2Completed
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
Pilot Study of Oral Cryotherapy vs. Oral Cryotherapy Plus Acupuncture and Acupressure to Decrease Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy for GI Cancers
- Outcome
- Results posted; no analysis attached
- Phase
- Phase 2
- Status
- Completed
- Study type
- Interventional
- Start
- 1 June 2021
- Ended
- 31 March 2024
- Enrollment
- 78 participants
- Sites
- 1
- Primary outcomes
- Change in Severity of Chemotherapy-induced Peripheral Neuropathy (CIPN) From Baseline to 3 Months
- Sponsor type
- Academic / other
- Results posted
- 21 January 2026
- Last update
- 21 January 2026
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Results
- Primary endpoint
- Results posted; no analysis attachedAs posted on ClinicalTrials.gov ↗, registry record of 21 January 2026
- Primary outcome
- Change in Severity of Chemotherapy-induced Peripheral Neuropathy (CIPN) From Baseline to 3 MonthsSensory Subscale: Arm I (Acupuncture, Acupressure, Cryotherapy): 5.9 (-7.4 to 37.0), n = 20Sensory Subscale: Arm II (Cryotherapy): 9.1 (-11.1 to 25.9), n = 27Motor Subscale: Arm I (Acupuncture, Acupressure, Cryotherapy): 1.9 (-16.7 to 12.5), n = 20Motor Subscale: Arm II (Cryotherapy): 5.7 (-4.2 to 25.0), n = 27Autonomic Subscale: Arm I (Acupuncture, Acupressure, Cryotherapy): 0.6 (-33.3 to 22.2), n = 20Autonomic Subscale: Arm II (Cryotherapy): 0.8 (-50.0 to 44.4), n = 27Values: mean units on a scale, Full RangeTime frame: At 3 monthsNo analysis posted for this outcome (outcome 1)
- Participants
- Arm I (Acupuncture, Acupressure, Cryotherapy): 37 started, 33 completedArm II (Cryotherapy): 41 started, 36 completed
- Serious adverse events
- Arm I (Acupuncture, Acupressure, Cryotherapy): 0 of 33Arm II (Cryotherapy): 0 of 36Participants with at least one serious adverse event, of those at risk, as posted
5 secondary outcomes
- Number of Participants With Grade 2 or Higher Chemotherapy-Induced Peripheral Neuropathy
- No Peripheral Sensory Neuropathy: Arm I (Acupuncture, Acupressure, Cryoth… 28/33; Arm II (Cryotherapy) 33/36 [Participants] (first of 2 rows)
- Severity of CIPN: Neuropen Assessment of Patients' Perceived Pressure
- Arm I (Acupuncture, Acupressure, Cryoth… -1.0 (4.4), n=21; Arm II (Cryotherapy) -0.7 (7.3), n=27 [mean proportion of present responses, Standard Deviation]
- Severity of CIPN: Tuning Fork Vibration Sensation Testing
- Arm I (Acupuncture, Acupressure, Cryoth… -5.0 (11.6), n=21; Arm II (Cryotherapy) 0.1 (6.6), n=27 [mean seconds, Standard Deviation]
- Proportion of Patients Assigned to the Intervention Arm Who Complete 60% of Acupuncture T…
- Adherent: Arm I (Acupuncture, Acupressure, Cryoth… 23/33 [Participants] (first of 2 rows)
- Change in Severity of Pain, Fatigue, Nausea, and Anxiety From Baseline to 3 Months
- Pain: Arm I (Acupuncture, Acupressure, Cryoth… -0.3 (1.2), n=19; Arm II (Cryotherapy) -0.3 (1.1), n=27 [mean units on a scale, Standard Deviation] (first of 4 rows)
Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This phase II trial investigates how well oral cryotherapy plus acupressure and acupuncture compared with oral cryotherapy alone work in decreasing chemotherapy-induced peripheral neuropathy in patients with gastrointestinal cancer who are receiving oxaliplatin-based chemotherapy. Acupressure is the application of pressure or localized massage to specific sites on the body to control symptoms such as pain or nausea. Acupuncture is the technique of inserting thin needles through the skin at specific points on the body to control pain and other symptoms. Cryotherapy uses cold temperature such as oral ice chips to prevent abnormally increased pain sensation. Giving oral cryotherapy with acupressure and acupuncture may work better in decreasing chemotherapy-induced peripheral neuropathy from oxaliplatin-based chemotherapy in patients with gastrointestinal cancer compared to oral cryotherapy alone.
Detailed description public domain (ClinicalTrials.gov)
OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients undergo acupuncture during chemotherapy infusion on day 1 and fluorouracil pump disconnect on day 3 of each biweekly chemotherapy infusion over 12 weeks. Patients also undergo self-administered acupressure over 11 minutes daily for 12 weeks and undergo standard of care oral cryotherapy. ARM II: Patients undergo standard of care oral cryotherapy.
Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)
Change in Severity of Chemotherapy-induced Peripheral Neuropathy (CIPN) From Baseline to 3 Months [At 3 months]. Mean, units on a scale (Full Range). Sensory Subscale: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=20): 5.9 (-7.4 to 37.0); Arm II (Cryotherapy) (n=27): 9.1 (-11.1 to 25.9). Motor Subscale: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=20): 1.9 (-16.7 to 12.5); Arm II (Cryotherapy) (n=27): 5.7 (-4.2 to 25.0). Autonomic Subscale: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=20): 0.6 (-33.3 to 22.2); Arm II (Cryotherapy) (n=27): 0.8 (-50.0 to 44.4).
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
Number of Participants With Grade 2 or Higher Chemotherapy-Induced Peripheral Neuropathy [3 months]. Count Of Participants, Participants. No Peripheral Sensory Neuropathy: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=33): 28; Arm II (Cryotherapy) (n=36): 33. Peripheral Sensory Neuropathy: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=33): 5; Arm II (Cryotherapy) (n=36): 3.
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
Severity of CIPN: Neuropen Assessment of Patients' Perceived Pressure [3 months]. Mean, proportion of present responses (Standard Deviation). Arm I (Acupuncture, Acupressure, Cryotherapy) (n=21): -1.0 (4.4); Arm II (Cryotherapy) (n=27): -0.7 (7.3).
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
Severity of CIPN: Tuning Fork Vibration Sensation Testing [3 months]. Mean, seconds (Standard Deviation). Arm I (Acupuncture, Acupressure, Cryotherapy) (n=21): -5.0 (11.6); Arm II (Cryotherapy) (n=27): 0.1 (6.6).
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
Proportion of Patients Assigned to the Intervention Arm Who Complete 60% of Acupuncture Treatments [3 months]. Count Of Participants, Participants. Adherent: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=33): 23. Nonadherent: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=33): 10.
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
Change in Severity of Pain, Fatigue, Nausea, and Anxiety From Baseline to 3 Months [3 months]. Mean, units on a scale (Standard Deviation). Pain: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=20): -0.3 (1.2); Arm II (Cryotherapy) (n=27): -0.3 (1.1). Fatigue: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=20): -0.1 (0.9); Arm II (Cryotherapy) (n=27): 0.4 (1.2). Nausea: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=20): -0.3 (0.7); Arm II (Cryotherapy) (n=27): 0.3 (1.0). Anxiety: Arm I (Acupuncture, Acupressure, Cryotherapy) (n=20): -0.1 (1.0); Arm II (Cryotherapy) (n=27): -0.1 (0.9).